Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
NCT ID: NCT06276309
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2024-02-01
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma
NCT07240753
Clinical Study on the Evaluation of the Efficacy of Cervical Cancer
NCT06254729
A Cohort Study of Uterine Malignancies
NCT05635123
Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer
NCT01628757
Clinical Database and Biobank of Patients With Gynecologic Neoplasms
NCT01267851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
(1) The diagnosis and treatment information of cervical neuroendocrine carcinoma in multiple hospitals was collected, including clinical and medical data such as age, preoperative HPV genotyping, preoperative biopsy pathological results, postoperative histopathological results, FIGO staging, prognosis and survival information, and follow-up of patients.
2\. Protein and other omics analysis was performed on paraffin tissues of 100 cases of cervical neuroendocrine tumors Paraffin samples collected from 100 cases of cervical neuroendocrine tumors were identified, processed and segmtioned, and protein concentration and proteome were determined to establish the molecular characteristics and prognostic targets of cervical neuroendocrine tumors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Clinical data were complete
Exclusion Criteria
2. Patients with lack of follow-up data, unable to obtain survival information
3. Patients call to refuse to participate in this project
4. The quality of paraffin specimens can not meet the requirements of proteome concentration determination
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fujian Maternity and Child Health Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pengming Sun, PhD
Role: STUDY_CHAIR
Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fujian Maternity and Child Health Hospital
Fuzhou, Fujian, China
Fujian Provincial Hospital
Fuzhou, Fujian, China
Ningde Mindong Hospital
Ningde, Fujian, China
Putian City first Hospital
Putian, Fujian, China
The Second Affiliated Hospital of Fujian Medical University
Quanzhou, Fujian, China
Zhangzhou affiliated Hospital of Fujian Medical University
Zhangzhou, Fujian, China
Maternal and Child Health Hospital of Hubei Province
Wuhan, Hubei, China
Xiangya Hospital, Central South University
Changsha, Hunan, China
Jiangxi maternal and Child Health Hospital
Nanchang, Jiangxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dongjie Chen
Role: primary
Fang Xie
Role: primary
Yi Chen
Role: primary
Luhong Li
Role: primary
Feifeng Shi, M.D
Role: primary
Hongning Cai, M.D
Role: primary
Yu Zhang
Role: primary
Ling Li
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NECC2401
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.